Dose‑dependent effect of Curcuma longa for the treatment of Parkinson's disease

Ma,Xiao‑Wei; Guo,Rui‑You

doi:10.3892/etm.2017.4225

Dose‑dependent effect of Curcuma longa for the treatment of Parkinson's disease

Authors:
- Xiao‑Wei Ma
- Rui‑You Guo
View Affiliations

Affiliations: Department of Neurology, Haici Hospital Affiliated to Medical College of Qingdao University, Qingdao, Shandong 266000, P.R. China
Published online on: March 10, 2017 https://doi.org/10.3892/etm.2017.4225
Pages: 1799-1805
Copyright: © Ma et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Curcuma longa is a plant that belongs to the ginger family, Zingiberaceae. It has been used in Siddha medicine for thousands of years in Asia. Parkinson's disease (PD) is a degenerative disorder of the central nervous system that affects the motor system of the brain. Death of dopamine‑producing cells in the substantia nigra leads to PD. Exposure to salsolinol, which is an endogenous neurotoxin, has been associated with damage to dopamine‑producing cells. The present study assessed the toxicity of salsolinol in SH‑SY5Y human neuroblastoma cells and subsequently investigated the neuroprotective potential of C. longa extract in salsolinol‑induced toxic conditions in SH‑SY5Y cells. Sulphorhodamine‑B assay showed the protective effect of the anti‑apoptotic effect of treated SH‑SY5Y cells. Fluorescence microscopy and confocal laser scanning microscope analysis indicated the anti‑apoptotic impact of the C. longa extract. Mitochondria‑derived reactive oxygen species were reduced in C. longa extract‑treated SH‑SY5Y cells. Downregulated mRNA expression levels of p53, Bcl‑2‑associated X protein and caspase 3 were observed in the C. longa extract‑treated SH‑SY5Y cells. Caspase 3 activity was reduced in the C. longa extract‑treated SH‑SY5Y cells. In conclusion, the present findings demonstrated that solsolinol is neurotoxic to SH‑SY5Y cells, and C. longa extract may be useful in the treatment of PD.

View Figures

View References

1	Chattopadhyay I, Biswas K, Bandyopadhyay U and Banerjee RK: Turmeric and curcumin: Biological actions and medicinal applications. Curr Sci. 87:44–53. 2004.
2	Khalsa SVK: Turmeric. The Golden Healer. http://www.healthy.net/recipe/health/turmeric_the_golden_healer/47Accessed. 2013.
3	Chaturvedi TP: Uses of turmeric in dentistry: An update. Indian J Dent Res. 20:107–109. 2009. View Article : Google Scholar : PubMed/NCBI
4	Tayyem RF, Heath DD, Al-Delaimy WK and Rock CL: Curcumin content of turmeric and curry powders. Nutr Cancer. 55:126–131. 2006. View Article : Google Scholar : PubMed/NCBI
5	Aggarwal BB and Harikumar KB: Potential therapeutic effects of curcumin, the anti-inflammatory agent, against neurodegenerative, cardiovascular, pulmonary, metabolic, autoimmune and neoplastic diseases. Int J Biochem Cell Biol. 41:40–59. 2009. View Article : Google Scholar : PubMed/NCBI
6	Jurenka JS: Anti-inflammatory properties of curcumin, a major constituent of Curcuma longa: A review of preclinical and clinical research. Altern Med Rev. 14:141–153. 2009.PubMed/NCBI
7	Sandur SK, Ichikawa H, Pandey MK, Kunnumakkara AB, Sung B, Sethi G and Aggarwal BB: Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic Biol Med. 43:568–580. 2007. View Article : Google Scholar : PubMed/NCBI
8	Kulkarni SK, Bhutani MK and Bishnoi M: Antidepressant activity of curcumin: Involvement of serotonin and dopamine system. Psychopharmacology (Berl). 201:435–442. 2008. View Article : Google Scholar : PubMed/NCBI
9	Bhutani MK, Bishnoi M and Kulkarni SK: Anti-depressant like effect of curcumin and its combination with piperine in unpredictable chronic stress-induced behavioral, biochemical and neurochemical changes. Pharmacol Biochem Behav. 92:39–43. 2009. View Article : Google Scholar : PubMed/NCBI
10	Li YC, Wang FM, Pan Y, Qiang LQ, Cheng G, Zhang WY and Kong LD: Antidepressant-like effects of curcumin on serotonergic receptor-coupled AC-cAMP pathway in chronic unpredictable mild stress of rats. Prog Neuropsychopharmacol Biol Psychiatry. 33:435–449. 2009. View Article : Google Scholar : PubMed/NCBI
11	Hurley LL, Akinfiresoye L, Nwulia E, Kamiya A, Kulkarni AA and Tizabi Y: Antidepressant-like effects of curcumin in WKY rat model of depression is associated with an increase in hippocampal BDNF. Behav Brain Res. 239:27–30. 2013. View Article : Google Scholar : PubMed/NCBI
12	Ng TP, Chiam PC, Lee T, Chua HC, Lim L and Kua EH: Curry consumption and cognitive function in the elderly. Am J Epidemiol. 164:898–906. 2006. View Article : Google Scholar : PubMed/NCBI
13	Aggarwal BB, Sundaram C, Malani N and Ichikawa H: Curcumin: The Indian solid gold. Adv Exp Med Biol. 595:1–75. 2007. View Article : Google Scholar : PubMed/NCBI
14	Tieu K: A guide to neurotoxic animal models of Parkinson's disease. Cold Spring Harb Perspect Medicine. 1:a0093162011. View Article : Google Scholar
15	Mravec B: Salsolinol, a derivate of dopamine, is a possible modulator of catecholaminergic transmission: A review of recent developments. Physiol Res. 55:353–364. 2006.PubMed/NCBI
16	Antkiewicz-Michaluk L: Endogenous risk factors in Parkinson's disease: Dopamine and tetrahydroisoquinolines. Pol J Pharmacol. 54:567–572. 2002.PubMed/NCBI
17	Maruyama W, Dostert P, Matsubara K and Naoi M: N-methyl(R)salsolinol produces hydroxyl radicals: Involvement to neurotoxicity. Free Radic Biol Med. 19:67–75. 1995. View Article : Google Scholar : PubMed/NCBI
18	Moser A, Siebecker F, Vieregge P, Jaskowski P and Kömpf D: Salsolinol, catecholamine metabolites, and visual hallucinations in L-dopa treated patients with Parkinson's disease. J Neural Transm Vienna. 103:421–432. 1996. View Article : Google Scholar : PubMed/NCBI
19	Alladi PA, Mahadevan A, Yasha TC, Raju TR, Shankar SK and Muthane U: Absence of age-related changes in nigral dopaminergic neurons of Asian Indians: Relevance to lower incidence of Parkinson's disease. Neuroscience. 159:236–245. 2009. View Article : Google Scholar : PubMed/NCBI
20	Darvesh AS, Carroll RT, Bishayee A, Novotny NA, Geldenhuys WJ and Van der Schyf CJ: Curcumin and neurodegenerative diseases: A perspective. Expert Opin Investig Drugs. 21:1123–1140. 2012. View Article : Google Scholar : PubMed/NCBI
21	Ramlochansingh C, Taylor RE and Tizabi Y: Toxic effects of low alcohol and nicotine combinations in SH-SY5Y cells are apoptotically mediated. Neurotox Res. 20:263–269. 2011. View Article : Google Scholar : PubMed/NCBI
22	Brown D, Tamas A, Reglödi D and Tizabi Y: PACAP protects against salsolinol-induced toxicity in dopaminergic SH-SY5Y cells: Implication for Parkinson's disease. J Mol Neurosci. 50:600–607. 2013. View Article : Google Scholar : PubMed/NCBI
23	Muthuraman P, Gansukh E, Bhupendra M, Murugesan C, Rafi N and Kim DH: Investigation of the role of aspartame on apoptosis process in Hela cells. Saudi J Biol Sci. June 15–2015.(Epub ahead of print). doi:10.1016/j.sjbs.2015.06.001.
24	Muthuraman P, Gansukh E, Baskar V, Bhupendra M, Rafi N, Bong YJ and Kim DH: Time and concentration-dependent therapeutic potential of silver nanoparticles in cervical carcinoma cells. Biol Trace Elem Res. 170:309–319. 2016. View Article : Google Scholar : PubMed/NCBI
25	Kirkland RA, Windelborn JA, Kasprzak JM and Franklin JL: A Bax-induced pro-oxidant state is critical for cytochrome c release during programmed neuronal death. J Neurosci. 22:6480–6490. 2002.PubMed/NCBI
26	Pandurangan M, Veerappan M and Kim DH: Cytotoxicity of zinc oxide nanoparticles on antioxidant enzyme activities and mRNA expression in the cocultured C2C12 and 3T3-L1 cells. Appl Biochem Biotechnol. 175:1270–1280. 2015. View Article : Google Scholar : PubMed/NCBI
27	Pfaffl MW: A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29:e452001. View Article : Google Scholar : PubMed/NCBI
28	Muthuraman P: Effect of cortisol on caspases in the co-cultured C2C12 and 3 T3-L1 cells. Appl Biochem Biotechnol. 173:980–988. 2014. View Article : Google Scholar : PubMed/NCBI
29	Frankfurt OS and Krishan A: Apoptosis-based drug screening and detection of selective toxicity to cancer cells. Anticancer Drugs. 14:555–561. 2003. View Article : Google Scholar : PubMed/NCBI
30	Das JR and Tizabi Y: Additive protective effects of donepezil and nicotine against salsolinol-induced cytotoxicity in SH-SY5Y cells. Neurotox Res. 16:194–204. 2009. View Article : Google Scholar : PubMed/NCBI
31	Song JX, Shaw PC, Wong NS, Sze CW, Yao XS, Tang CW, Tong Y and Zhang YB: Chrysotoxine, a novel bibenzyl compound selectively antagonizes MPP⁺, but not rotenone, neurotoxicity in dopaminergic SH-SY5Y cells. Neurosci Lett. 521:76–81. 2012. View Article : Google Scholar : PubMed/NCBI
32	Storch A, Kaftan A, Burkhardt K and Schwarz J: 1-Methyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline (salsolinol) is toxic to dopaminergic neuroblastoma SH-SY5Y cells via impairment of cellular energy metabolism. Brain Res. 855:67–75. 2000. View Article : Google Scholar : PubMed/NCBI
33	Zhang Y, Wang L, Mu X, Duan J, Zhu Y, Qing H, Li Y, Xiao S and Deng Y: Assessment of salsolinol N methyltransferase activity in rat peripheral lymphocytes by liquid chromatography-electrospray time-of-flight mass spectrometry. Anal Bioanal Chem. 399:3541–3545. 2011. View Article : Google Scholar : PubMed/NCBI
34	Copeland RL Jr, Das JR, Kanaan YM, Taylor RE and Tizabi Y: Antiapoptotic effects of nicotine in its protection against salsolinol-induced cytotoxicity. Neurotox Res. 12:61–69. 2007. View Article : Google Scholar : PubMed/NCBI
35	Worth PF: How to treat Parkinson's disease in 2013. Clin Med. 13:93–96. 2013. View Article : Google Scholar